Translational Working Group

Translational Working Group:

Taking ARC’s findings from pipette to point of care

Andrea Beaton

Rachel Sarnacki

Co-Chair

Michael Levin

Jonathan Carapetis

Co-Chair

Ganesan Karthikeyan

Program Manager

Member

Scott Tebbutt

Member

Nikki Moreland

Member

Member

The Translational Working Group (TWG) is dedicated to transforming scientific discoveries into tangible health solutions. By focusing on strategic planning and collaboration, the TWG aims to ensure that innovations progress seamlessly from the research phase to practical application. The leadership of this group consists of: Andrea Beaton and Jonathan Carapetis as Co-Chairs, Rachel Sarnacki as Program Manager, and Ganesan Karthikeyan, Mike Levin, and Scott Tebbutt as Members of the working group.

Leadership Team:
Co-Chairs:
Andrea Beaton & Jonathan Carapetis
Program Manager: Rachel Sarnacki
Members: Ganesan Karthikeyan, Michael Levin, Scott Tebbutt

Key Outputs:

Landscape Assessment: Conducting comprehensive evaluations of both market and non-market environments to identify opportunities and challenges in the translational landscape

Stakeholder Mapping & Advocacy Planning: Identifying and engaging key stakeholders, while developing strategic advocacy plans to support the translation process

Partner and Advisor Outreach: Scoping and reaching out to potential partners and advisors who can contribute expertise and resources to the translational efforts.

Preferred Product Characteristics: Defining the desired attributes and specifications of the product to guide development and ensure alignment with market needs.

Partnership & Outcome Criteria: Establishing criteria for selecting partners and measuring outcomes to ensure successful collaborations and impactful results

Development Pathway (Pipeline): Mapping out the stages of product development, from concept to commercialization, to ensure a structured and efficient process.

Business Plan & Pitch Deck: Creating comprehensive business plans and compelling pitch decks to attract investment and support for the translational initiatives

Partnership Agreement: Drafting clear and mutually beneficial partnership agreements to formalize collaborations and delineate roles and responsibilities

Through these strategic outputs, the TWG aims to facilitate the seamless transition of research innovations into practical applications, ultimately improving health outcomes and advancing scientific progress.